|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0024554,
umls-concept:C0039225,
umls-concept:C0042960,
umls-concept:C0150097,
umls-concept:C0201734,
umls-concept:C0220825,
umls-concept:C0285590,
umls-concept:C0524527,
umls-concept:C1549078,
umls-concept:C1556095,
umls-concept:C1997894
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-1-29
|
|
pubmed:abstractText |
Bicalutamide is an oral nonsteroidal antiandrogen drug used during hormone ablation therapy for prostate cancer. A new generic formulation of bicalutamide has been developed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1879-114X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 Excerpta Medica Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3000-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20110037-Administration, Oral,
pubmed-meshheading:20110037-Adult,
pubmed-meshheading:20110037-Androgen Antagonists,
pubmed-meshheading:20110037-Anilides,
pubmed-meshheading:20110037-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20110037-Area Under Curve,
pubmed-meshheading:20110037-Asian Continental Ancestry Group,
pubmed-meshheading:20110037-Chemistry, Pharmaceutical,
pubmed-meshheading:20110037-Chromatography, High Pressure Liquid,
pubmed-meshheading:20110037-Cross-Over Studies,
pubmed-meshheading:20110037-Drugs, Generic,
pubmed-meshheading:20110037-Humans,
pubmed-meshheading:20110037-Korea,
pubmed-meshheading:20110037-Male,
pubmed-meshheading:20110037-Middle Aged,
pubmed-meshheading:20110037-Nitriles,
pubmed-meshheading:20110037-Tablets,
pubmed-meshheading:20110037-Tandem Mass Spectrometry,
pubmed-meshheading:20110037-Therapeutic Equivalency,
pubmed-meshheading:20110037-Tosyl Compounds,
pubmed-meshheading:20110037-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.
|
|
pubmed:affiliation |
Department of Pharmacology and Clinical Pharmacology, Seoul National University College of Medicine and Hospital, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
